| 1 |
35283454 | Five-Year Outcome of an Early Everolimus-based Quadruple Immunosuppression in Lung Transplant Recipients: Follow-Up of the 4EVERLUNG Study. | 2022 Mar 8 |
3 |
| 2 |
33795116 | Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study). | 2021 Apr |
1 |
| 3 |
34216395 | Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study. | 2021 Oct |
1 |
| 4 |
30893292 | Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study. | 2020 Jan |
1 |
| 5 |
32059083 | Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients. | 2020 Apr |
1 |
| 6 |
32113691 | Long-Term Effects of the Replacement of Calcineurin Inhibitors With Everolimus and Mycophenolate in Patients With Calcineurin Inhibitor-Related Nephrotoxicity. | 2020 Apr |
1 |
| 7 |
32307148 | Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose and Hemoglobin Concentration in Transplant Patients Treated With Proliferation Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus). | 2020 Oct |
1 |
| 8 |
32317617 | Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study: Erratum. | 2020 May |
1 |
| 9 |
32633157 | Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study. | 2020 Oct |
1 |
| 10 |
30939587 | Suppressive Effect of Everolimus on IL-2, IL-10, IL-21, and IFNγ Levels: Implications for the Successful Minimization of Calcineurin Inhibitor Use in Transplantation. | 2019 Jun |
1 |
| 11 |
31060742 | Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports. | 2019 Jun |
1 |
| 12 |
31152476 | Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. | 2019 Nov |
1 |
| 13 |
29722128 | Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy. | 2018 Dec |
2 |
| 14 |
29752413 | Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. | 2018 Jul |
2 |
| 15 |
29954336 | Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study. | 2018 Jun 28 |
3 |
| 16 |
30097996 | Effect of Age on Conversion to Everolimus with Calcineurin Inhibitor Minimization at A Late Post-Transplant Stage. | 2018 Sep 26 |
3 |
| 17 |
30211023 | Introduction of everolimus in kidney transplant recipients at a late posttransplant stage. | 2018 Sep 10 |
2 |
| 18 |
27915965 | Systematic Review on Role of Mammalian Target of Rapamycin Inhibitors as an Alternative to Calcineurin Inhibitors in Renal Transplant: Challenges and Window to Excel. | 2017 Jun |
1 |
| 19 |
28104152 | Experience of Quatro-Therapy With Everolimus to Minimize Calcineurin Inhibitor for Kidney Transplant Recipients. | 2017 Jan - Feb |
1 |
| 20 |
28107397 | Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials. | 2017 |
3 |
| 21 |
28133906 | Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. | 2017 Jul |
1 |
| 22 |
28230646 | Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation. | 2017 Nov |
1 |
| 23 |
28878864 | Use of everolimus in liver transplantation. | 2017 Aug 18 |
1 |
| 24 |
26603484 | Everolimus immunosuppression in kidney transplantation: What is the optimal strategy? | 2016 Jan |
1 |
| 25 |
26820618 | Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study. | 2016 Apr |
2 |
| 26 |
26842532 | Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience. | 2016 Feb 4 |
1 |
| 27 |
27067532 | Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial. | 2016 Jul |
1 |
| 28 |
27160359 | Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study. | 2016 Jun |
2 |
| 29 |
27234735 | Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1 Year After Kidney Transplantation. | 2016 Apr |
2 |
| 30 |
27234736 | Effectiveness of the Combination of Everolimus and Tacrolimus With High Dosage of Mizoribine for Living Donor-Related Kidney Transplantation. | 2016 Apr |
2 |
| 31 |
24983307 | Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. | 2015 Jan |
1 |
| 32 |
25207429 | Progression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen. | 2015 Mar |
2 |
| 33 |
25783974 | The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial. | 2015 Jul |
2 |
| 34 |
25873064 | Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. | 2015 Mar 26 |
1 |
| 35 |
26031588 | Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. | 2015 Jul |
2 |
| 36 |
24206966 | Prospective study of everolimus with calcineurin inhibitor-free immunosuppression after heart transplantation: results at four years. | 2014 Mar |
4 |
| 37 |
24606320 | Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. | 2014 Sep |
1 |
| 38 |
24932812 | Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. | 2014 Aug |
2 |
| 39 |
23230975 | Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine. | 2013 Mar-Apr |
1 |
| 40 |
23422495 | Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation. | 2013 Apr 15 |
1 |
| 41 |
23621682 | Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen. | 2013 May-Jun |
1 |
| 42 |
24029254 | Safety and efficacy of everolimus in chronic allograft nephropathy. | 2013 Sep |
1 |
| 43 |
24128136 | Renal recovery after conversion to an everolimus-based immunosuppression in early and late heart transplant recipients: a 12-month analysis. | 2013 Oct |
1 |
| 44 |
21631587 | Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus. | 2012 Aug |
1 |
| 45 |
22333403 | Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. | 2012 Mar |
1 |
| 46 |
22404500 | Everolimus: preventing organ rejection in adult kidney transplant recipients. | 2012 Apr |
1 |
| 47 |
22466910 | Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study. | 2012 Jan-Mar |
2 |
| 48 |
22890040 | Everolimus in pediatric transplantation. | 2012 Oct |
1 |
| 49 |
22958738 | Virtual histology assessment of cardiac allograft vasculopathy following introduction of everolimus--results of a multicenter trial. | 2012 Oct |
1 |
| 50 |
21162600 | Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? | 2011 Feb 1 |
1 |